Coronavirus Treatment: ‘Game changer’ Hydroxychloroquine Fails Test; Doesn’t Benefit COVID-19 Patients
The study was published in the New England Journal of Medicine under certain limitations in which the doctors reported that the use of the drug could neither lessen the need for breathing assistance of the inmates nor did it control the death risks.
Read Original Article: Coronavirus Treatment: ‘Game changer’ Hydroxychloroquine Fails Test; Doesn’t Benefit COVID-19 Patients »
